Board of directors
Lars Bastiaanse, PhD
Chief Executive Officer
Lars Bastiaanse has a MSc degree in pharmacy and completed his PhD degree in Medicinal Sciences (cardiobiochemistry) at the Cardiology department of the Leiden University Medical Centre in Leiden, The Netherlands.
Lars joined Cardialysis in 2017 and has over 20 years of experience in clinical development, project management and general management in the pharmaceutical, biotech, and CRO/Consultancy business.
Prior to joining Cardialysis, Lars was with Johnson & Johnson in positions of increasing seniority. In addition, Lars was CEO for Kinesis Pharma and 3D-PharmXchange.
Gerrit-Anne van Es, PhD
Director of Research & Business Development
Gerrit-Anne van Es has a MSc degree in mathematics. He completed his PhD degree in biostatistics at the Erasmus Medical Centre in Rotterdam. After a position at the Epidemiology and Biostatistics Department of the Erasmus University of Rotterdam, he joined Cardialysis in 1992. In his current position, he is a member of the Executive Board of Cardialysis with responsibility for Research and Business Development. Dr. van Es has been involved in the conduct of clinical trials in the field of cardiology for 24 years. The areas of experience are: interventional cardiology, both device and pharma studies, thrombolytic therapy, atherosclerosis and heart surgery.
Since its start in 2012, Dr. van Es is Managing Director of the European Cardiovascular Research Institute (ECRI), which was founded as a non-profit organization to perform investigator initiated studies.
Irene Kuit, MA
Managing Director of Project Strategy
Irene Kuit joined Cardialysis in 2014 and has over 20 years of experience in clinical development in the CRO industry. In her current position, Irene is a member of the Executive Board of Cardialysis and develops business strategies and study delivery models for clinical studies. In her role, she is responsible for the direct operational oversight of Project Teams, as well as for the design, implementation, and maintenance of clinical operational processes.
Prior to joining Cardialysis, Irene assumed project management and key operational positions at Quintiles, PAREXEL, MIRAI/VERUM, Cardialysis and the Daniel Den Hoed cancer center. Her expertise lies in management principles and in the conduct of clinical trials in the field of cardiology (pharma and device). Irene has a MSc degree in Speech and Language Pathology at the University of Nijmegen, the Netherlands.